Where ICAM-1 is reported
Also listed as: Intercellular adhesion molecule
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Long COVID | ↑ elevated | healthy controls | Endothelial activation | Thomas et al. 2024 |
Frequently asked questions
In which conditions is ICAM-1 altered?
In the OSMF atlas ICAM-1 is reported in Long COVID. It is elevated in 1 across 1 entries.
Is there a standard clinical test for ICAM-1?
The atlas entries for ICAM-1 do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal ICAM-1 result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.